Evidence map›Paper›PMID 41244079›Full record

ReviewTropical parasitology

Blood parasitic diseases in India: Current landscape, challenges, and the road ahead.

Nonika Rajkumari, Diptanu Majumder

Abstract readReview
In one paragraph

Review in Tropical parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nonika RajkumariDepartment of Microbiology, AIIMS, Kalyani, West Bengal, India.
Diptanu MajumderDepartment of Microbiology, AIIMS, Kalyani, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood parasitic diseases remain a significant public health challenge in India, with malaria, lymphatic filariasis (LF), and visceral leishmaniasis (kala-azar) accounting for the highest disease burden among parasitic infections. India contributes a major share of the global burden, particularly for LF and kala-azar, and remains one of the few countries endemic for all three major blood parasites. These diseases remain endemic in several regions, particularly among marginalized and tribal populations. The complex epidemiology is compounded by asymptomatic carriers, atypical clinical manifestations, and coinfections, often leading to delayed diagnosis and incomplete treatment coverage. In addition, geographic inaccessibility, socio-economic deprivation, poor health-seeking behavior, and limited infrastructure further hinder elimination efforts. However, recent advances in molecular diagnostic methods and treatment strategies have opened a new window for precise detection and surveillance. This review provides a comprehensive overview of the current epidemiology, emerging challenges, and recent scientific and technological advances in the control and elimination of blood parasitic diseases in India. It emphasizes the critical need for a multisectoral, evidence-based approach, combining innovative tools, community engagement, and health system strengthening to achieve long-term, sustainable elimination.

Indexed as

Blood parasitesdrug resistanceeliminationkala-azarplasmodiumvaccines

Identifiers

PMID41244079
PMCPMC12617576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.